Definium Therapeutics, Inc. — All Filings
437 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B3
424B5
424B7
6-K
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFC14A
DFAN14A
EFFECT
F-10
F-10/A
F-X
PRE 14A
PREC14A
PRER14A
PRRN14A
S-3
S-3ASR
S-3MEF
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0000950170-25-086767 | Jun 16, 2025 | Jun 12, 2025 |
| 8-K | 8-K | 0000950170-25-086830 | Jun 16, 2025 | — |
| 4 | 4 | 0000950170-25-086763 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | 4 | 0000950170-25-086764 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | 4 | 0000950170-25-086765 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | 4 | 0000950170-25-086766 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | 4 | 0000950170-25-080407 | Jun 2, 2025 | — |
| 3 | 3 | 0000950170-25-080399 | Jun 2, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-052719 | May 27, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-001966 | May 15, 2025 | — |
| 8-K | 8-K | 0000950170-25-066374 | May 8, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-066387 | May 8, 2025 | Mar 31, 2025 |
| D | — | 0001123292-25-000190 | May 5, 2025 | — |
| ARS | ARS | 0001104659-25-038023 | Apr 23, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0001104659-25-038010 | Apr 23, 2025 | Jun 12, 2025 |
| DEFA14A | DEFA14A | 0001104659-25-038015 | Apr 23, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-036841 | Apr 21, 2025 | Apr 18, 2025 |
| 8-K | 8-K | 0000950170-25-053953 | Apr 15, 2025 | — |
| 4 | 4 | 0000950170-25-045397 | Mar 26, 2025 | Mar 25, 2025 |
| 4 | 4 | 0000950170-25-045393 | Mar 26, 2025 | Mar 25, 2025 |
| 4 | 4 | 0000950170-25-045394 | Mar 26, 2025 | Mar 25, 2025 |
| 4 | 4 | 0000950170-25-045396 | Mar 26, 2025 | Mar 25, 2025 |
| 144 | — | 0001950047-25-002178 | Mar 25, 2025 | — |
| 144 | — | 0001950047-25-002183 | Mar 25, 2025 | — |
| 144 | — | 0001950047-25-002185 | Mar 25, 2025 | — |
| 144 | — | 0001950047-25-002186 | Mar 25, 2025 | — |
| 4 | 4 | 0000950170-25-041302 | Mar 18, 2025 | Mar 17, 2025 |
| 3 | 3 | 0000950170-25-041260 | Mar 18, 2025 | Mar 17, 2025 |
| 4 | 4 | 0000950170-25-038801 | Mar 13, 2025 | Mar 12, 2025 |
| 4 | 4 | 0000950170-25-038798 | Mar 13, 2025 | Mar 12, 2025 |
| 4 | 4 | 0000950170-25-038796 | Mar 13, 2025 | Mar 12, 2025 |
| 4 | 4 | 0000950170-25-038800 | Mar 13, 2025 | Mar 12, 2025 |
| 8-K | 8-K | 0000950170-25-034175 | Mar 6, 2025 | — |
| 10-K | 10-K | 0000950170-25-034176 | Mar 6, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | — | 0002012383-25-001448 | Feb 5, 2025 | — |
| 8-K | 8-K | 0000950170-25-010802 | Jan 30, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-002868 | Jan 13, 2025 | Jan 10, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-132167 | Dec 27, 2024 | Dec 26, 2024 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-132164 | Dec 27, 2024 | Dec 26, 2024 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-132160 | Dec 27, 2024 | Dec 26, 2024 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-132166 | Dec 27, 2024 | Dec 26, 2024 |
| 144 | — | 0001950047-24-010083 | Dec 26, 2024 | — |
| 144 | — | 0001950047-24-010084 | Dec 26, 2024 | — |
| 144 | — | 0001950047-24-010085 | Dec 26, 2024 | — |
| 144 | — | 0001950047-24-010086 | Dec 26, 2024 | — |
| 8-K | 8-K | 0000950170-24-136386 | Dec 16, 2024 | — |
| 4 | 4 | 0000950170-24-133724 | Dec 5, 2024 | — |
| SC 13G/A | — | 0001493152-24-045841 | Nov 14, 2024 | — |
| SC 13G | — | 0002012383-24-003562 | Nov 8, 2024 | — |
| 8-K | 8-K | 0000950170-24-123366 | Nov 7, 2024 | — |